Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia Recruitment opened
- Notable: Predictive Value of Microemboli Detected by Robotic Transcranial Doppler (TCD) for the Occurrence of an Acute Ischemic Stroke (AIS) or Left Ventricular Thrombus (LVT) in ST Elevation Myocardial Infarction (STEMI) · Left Ventricular Dysfunction (LVD) Recruitment opened
- Notable: Between Opioid-sparing Anesthesia Guided by the CARDEAN® Index and Opioid-free Anesthesia During Total Hip Arthroplasty Recruitment opened
- Notable: Synthetic Mesh · HernIa After opEn Abdomen cLosure stuDy Recruitment opened
- Notable: Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain · Renal Insufficiency Recruitment opened
- Notable: Correlation Between Forward Head Posture and Executive Functions in Cervical Radiculopathy Recruitment opened
- Notable: Online Pain Education for Crohn's Disease and Ulcerative Colitis Enrolling by invitation only
- Notable: Laser Irradiation on the Veins and Acupoints on Arterial Stiffness · Cardio-renal Metabolic Syndrome Enrolling by invitation only
- Notable: Biomarker Investigation for Early Gastric Cancer Detection Recruitment opened
- Notable: Outcome of Concurrent Versus Sequential Method of Induction of Labour in Term Pregnancy Recruitment opened
- Notable: GLP-1RAs on Fertility Outcomes in Obese · PCOS Recruitment opened
- Notable: Orofacial Myofunctional Therapy and Cervical Stabilization Exercises · Axis-i Group Iia Temporomandibular Dysfunction Recruitment opened
- Notable: Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1 Recruitment opened
- Notable: Sibeprenlimab in Children and · Immunoglobulin A Nephropathy (IgAN) Start date pushed from Oct 30, 2026 to Nov 30, 2026
- Notable: T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd Start date pushed from Sep 18, 2026 to Nov 4, 2026
- Notable: Adjunctive Troriluzole in Obsessive Compulsive Disorder Results posted: Nov 17, 2026
- Notable: INCB123667 Versus Investigator's Choice of Chemotherapy · Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression Primary and study completion dates moved earlier to Oct 12, 2027
- Notable: Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response Eligibility criteria changed
- Notable: Topical SGX302 for Mild-to-Moderate Psoriasis Results posted: Nov 17, 2026
- Notable: NAI Plus Standard of Care Compared To SOC Alone Plus Standard of Care · Sepsis Start date pushed from Oct 15, 2026 to Jan 15, 2027
- Notable: LY4405094 in Healthy Participants and · Alzheimer's Disease Start date pushed from Oct 14, 2025 to Oct 10, 2026
- Notable: THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator · Drug Refractory Symptomatic PAFOUS Results posted: Nov 17, 2026
- Notable: Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease Eligibility criteria changed
- Notable: CRPS-RISE Outcomes Registry Start date pushed from Sep 17, 2026 to Oct 17, 2026
- Notable: 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations Eligibility criteria changed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates